News

Read our latest posts

Milford, NH. Prediction Sciences and Affinity Life Sciences , today announced a development and commercialization agreement of a biomarker assay, cellular fibronectin; for the identification and use of a research diagnostic marker for stroke, vascular damage and hemorrhagic transformation (HT). Upon completion of development and...